Alan Glicklich Chinook Therapeutics, Inc. (KDNY) insider trading activity

KDNY Quotes by TradingView

Alan Glicklich is Chief Medical Officer of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 7,891 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Feb 11, 2022, when has been sold 2,391 shares (Common Stock) at a price of $12.74 per share, resulting in proceeds of $30,461. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.89K
0% 3M change
0% 12M change
Total Value Held $0

Alan Glicklich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 11 2022
SELL
Open market or private sale
$30,461 $12.74 p/Share
2,391 Reduced 23.25%
7,891 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
5,668 Added 35.54%
10,282 Common Stock
Oct 06 2021
SELL
Payment of exercise price or tax liability
$30,789 $12.37 p/Share
2,489 Reduced 35.04%
4,614 Common Stock
Oct 06 2021
BUY
Exercise of conversion of derivative security
-
7,103 Added 50.0%
7,103 Common Stock
Jun 16 2021
SELL
Open market or private sale
$327,000 $16.35 p/Share
20,000 Reduced 100.0%
0 Common Stock
Jun 16 2021
BUY
Exercise of conversion of derivative security
$8,400 $0.42 p/Share
20,000 Added 50.0%
20,000 Common Stock
AG

Alan Glicklich

Chief Medical Officer
Seattle, WA

Track Institutional and Insider Activities on KDNY

Follow CHINOOK THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KDNY shares.

Notify only if

Insider Trading

Get notified when an Chinook Therapeutics, Inc. insider buys or sells KDNY shares.

Notify only if

News

Receive news related to CHINOOK THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KDNY